Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility
Abstract Isocitrate lyase (ICL), a potential anti-tubercular drug target, catalyzes the first step of the glyoxylate shunt. In the present investigation, we studied the conformational flexibility of MtbICL to better understand its stability and catalytic activity. Our biochemical results showed that...
Guardado en:
Autores principales: | Harish Shukla, Rohit Shukla, Amit Sonkar, Tripti Pandey, Timir Tripathi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b886f7c010434bc289f4df6ea8facbd5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2
por: Ram Prasad Bhusal, et al.
Publicado: (2019) -
Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
por: Sunghark Kwon, et al.
Publicado: (2021) -
¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.
por: Dany J V Beste, et al.
Publicado: (2011) -
Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine
por: Zhang X, et al.
Publicado: (2020) -
Role of PheE15 gate in ligand entry and nitric oxide detoxification function of mycobacterium tuberculosis truncated hemoglobin N.
por: Ana Oliveira, et al.
Publicado: (2012)